Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: Retrospective analysis of the US Carvedilol Heart Failure Trials Program
- 1 September 2001
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 142 (3), 498-501
- https://doi.org/10.1067/mhj.2001.117318
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Impact of Atrial Fibrillation on the Risk of DeathCirculation, 1998
- Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trialsJournal of the American College of Cardiology, 1998
- Impact of Atrial Fibrillation on Mortality, Stroke, and Medical CostsArchives of Internal Medicine, 1998
- Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart FailureCirculation, 1996
- Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart FailureCirculation, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effects of Carvedilol, a Vasodilator–β-Blocker, in Patients With Congestive Heart Failure Due to Ischemic Heart DiseaseCirculation, 1995
- Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients.Circulation, 1991